baber/WOPTO huggingface dataset:
Patent JP-2888845-B2 (JP)
IPC: B65D75/62
Filed: 1988-03-22
Granted: 1999-05-10
Abstract: The invention relates to a removal aid for mechanically detachable substrates adhering to a sheet-like, flexible carrier material and in the form of cuts or predetermined breaking lines in said carrier material. At least in the contact surface of the carrier material is provided for each substrate a separate, non-linear cutting or predetermined breaking line, so that when pressure is exerted on the carrier material with a force component in a direction at right angles to the substrate contact surface a carrier material portion with the substrate portion adhering thereto and bounded by the cutting or predetermined breaking line can be bent in the direction of the substrate or substrates, so that at least part of the substrate in the border area thereof adjacent to the cutting or predetermined breaking line is detached from the carrier material and consequently a gripping portion is formed on the substrate for the complete removal of the latter.
Patent JP-3555761-B2 (JP)
IPC: A61F13/511
Filed: 1992-07-23
Granted: 2004-08-18
Abstract: A napkin comprises an absorbent core between a pervious topsheet and an impervious backsheet, with all parts extensible, and a fastener for securing the napkin to the garment, the fastener allowing at least parts of the napkin to extend. The napkin is pref. extensible both longitudinally and transversely and may require extending before applying to the garment, or may be extended by forces applied during use. Stretched length is pref. at least 25% greater than unstretched length. The napkin may be provided with a pull-out tab so that the user can lengthen the napkin.
Patent JP-2594046-B2 (JP)
IPC: C03C17/02
Filed: 1986-06-19
Granted: 1997-03-26
Abstract: The guiding layers of optical waveguides are formed of arsenosilicate glass (ASG). By varying the arsenic content from 2 to 13 mole per cent it is possible to vary the refractive index in the range 1.45 to 1.53. Pure silica or less heavily doped ASG can be used for the cladding layers. The ASG is preferably formed as the result of a heterogeneous reaction between silane and oxygen in the presence of arsine. Such a reaction can be carried out at temperatures down to 390°C, allowing the ASG to be used on substrates of III-V compounds.
Patent JP-2655735-B2 (JP)
IPC: G02C7/06
Filed: 1989-05-08
Granted: 1997-09-24
Abstract: PCT No. PCT/IT89/00033 Sec. 371 Date Nov. 23, 1990 Sec. 102(e) Date Nov. 23, 1990 PCT Filed May 8, 1989 PCT Pub. No. WO89/11672 PCT Pub. Date Nov. 30, 1989.A multifocal contact lens, having progressive eccentricity in an area coaxial relative to the optical center, is obtained through the lens outer surface turning on a lathe, in the optical area involved, by means of a computer controlled lathe, based on special computer programs. The contact lens provided as said above allows vision problems concerning both far range vision and near range vision, in miopic or hypermetropic subjects, to be simultaneously corrected.
Patent JP-2853331-B2 (JP)
IPC: G06Q40/00
Filed: 1992-10-16
Granted: 1999-02-03
Abstract: PCT No. PCT/GB92/01901 Sec. 371 Date Aug. 16, 1993 Sec. 102(e) Date Aug. 16, 1993 PCT Filed Oct. 16, 1992 PCT Pub. No. WO93/08545 PCT Pub. Date Apr. 29, 1993.A plurality of electronic purses communicate with each other to transfer values in transactions off-line from a main computer. A transfer message protocol of a transaction between electronic purses includes a commitment message to constitute a proof of posting. This allows interruption of a transaction before the value message itself is set. Escrow type payments and batch processing are facilitated.
Patent JP-3819023-B2 (JP)
IPC: H03G7/00
Filed: 1994-09-19
Granted: 2006-09-06
Abstract: PCT No. PCT/FI94/00414 Sec. 371 Date May 19, 1995 Sec. 102(e) Date May 19, 1995 PCT Filed Sep. 19, 1994 PCT Pub. No. WO95/08877 PCT Pub. Date Mar. 30, 1995A transcoding and transdecoding unit in a digital mobile radio system, and methods for adjusting their output signals. The unit includes an expander for converting companded digital data into a linear signal; a speech encoder for coding a linearized signal into encoded form; and an amplifier for amplifying the expanded signal. In order that the outbound audio signal not suffer interference due to the raised level, the transcoding unit further includes a level monitor for monitoring the amplitude of the linearized signal and for controlling amplifier such that the signal produced by the amplifier is of a desired level.
Patent JP-3171262-B2 (JP)
IPC: G01N33/53
Filed: 1995-09-22
Granted: 2001-05-28
Abstract: Methods, devices and test kits for monitoring the ovulation cycle, involve testing the body fluid, e.g. urinary, concentration of one or more analytes. Preferably estrone-3-glucuronide and luteinizing hormone are both measured, and a reference concentration for E3G is established at about day 6 of the current cycle. Preferably, disposable testing devices are used, in conjunction with a relatively permanent electronic reader/monitor. The number of "daily" tests required per month can be minimised.
Patent JP-3105242-B2 (JP)
IPC: A01H5/10
Filed: 1990-08-09
Granted: 2000-10-30
Abstract: A plant, the nuclear genome of which is transformed with a foreign DNA sequence encoding a product which neutralizes the activity of another product which disrupts the metabolism, functioning and/or development selectively of the plant's flower cells, particularly reproductive organ cells, or seed cells or embryo cells. The foreign DNA sequence also optionally encodes a marker.
Patent JP-2598571-B2 (JP)
IPC: A23L27/60
Filed: 1990-09-12
Granted: 1997-04-09
Abstract: PCT No. PCT/NO/0000140 Sec. 371 Date Apr. 14, 1992 Sec. 102(e) Date Apr. 14, 1992 PCT Filed Sep. 12, 1990 PCT Pub. No. WO91/03943 PCT Pub. Date Apr. 4, 1991.The present invention is directed to a process for producing a marine oil preparation, in the form of an oil-in-water emulsion, with the viscosity of mayonnaise, containing 22 to 90% by weight of cod-liver oil or other marine oils, or concentrates of such oils, where the emulsion is filled into containers made of an air-resistant material and which follows closely the contents during and after dosage so that no air space arises and therefore no oxidation of the preparation occurs. The production process occurs preferably under an inert gas atmosphere.
Patent JP-3849143-B2 (JP)
IPC: H05B44/00
Filed: 1997-09-24
Granted: 2006-11-22
Abstract: A projection display apparatus employing organic EL elements is presented that is light in weight, is small in size, and can be practically implemented. In particular, the apparatus suppresses light-emission performance degradation caused by generated heat, thereby extending useful life, stabilizing brightness, and securing continual maximum brightness. The apparatus comprises: liquid crystal panels 12R, 12G, and 12B; light emitting units 13R, 13G, and 13B, positioned at the back of the liquid crystal panels and provided with organic EL elements as light emitting layers; and cooling bodies 14R, 14G, and 14B, positioned at the back of the light emitting units, for dispersing the heat generated by the light emitting layers. The cooling bodies 14R, 14G, and 14B may, for example, be electronic cooling elements that employ the Peltier effect to absorb and radiate the generated heat. Alternatively, the cooling bodies may be configured as heat-dispersing fins that guide and disperse generated heat. <IMAGE>
Patent JP-3448052-B2 (JP)
IPC: A61K31/765
Filed: 1991-10-10
Granted: 2003-09-16
Abstract: The present invention provides for proanthocyanidin polymers with significant antiviral activity. The proanthocyanidin polymers can be chemically synthesized or can be isolated from a Croton or a Calophyllum plant species. The present invention encompasses methods of using proanthocyanidin polymers in treating warm-blooded animals, including humans, infected with a respiratory virus.
Patent JP-3452574-B2 (JP)
IPC: B65H33/02
Filed: 1994-01-27
Granted: 2003-09-29
Abstract: PCT No. PCT/EP94/00219 Sec. 371 Date Aug. 28, 1995 Sec. 102(e) Date Aug. 28, 1995 PCT Filed Jan. 27, 1994 PCT Pub. No. WO94/19270 PCT Pub. Date Sep. 1, 1994The invention relates to a device for the non-stop operation of a delivery unit of a rotary printing machine in which sheets in a flow of sheets are collated into individual stacks supported on a stack base with a surface interrupted by grooves and in which auxiliary stacks are borne by grid rods together forming a rack until their transfer to the stack base, the grid rods penetrating into the grooves during transfer. To prevent the stacks from being hampered by their weight, according to the invention a receiving plate catching the auxiliary stack from below is laid upon the grid rods in their reception position.
Patent JP-3645264-B2 (JP)
IPC: B01F29/60
Filed: 1995-01-26
Granted: 2005-05-11
Abstract: The invention relates to a method of mixing cohesive finely divided powders such as finely divided powdered medicaments having a particle size less than about 10 mum comprising the combination of a rotating/vibrating movement with a sieving procedure, wherein the method comprises the steps of adding a finely divided powdered mixture of substances to a perforated partition in a container, subjecting the container to a rotational and preferably vibrating movement in horisontal and/or vertical directions whereby the rotational movement is performed in intervals and whereby the container is turned in a vertical direction an angle of substantially 180° during each turn.The invention also includes an apparatus for mixing finely divided powders to be used in the above mentioned method as well as the use of the method according to the invention for mixing cohesive finely divided powders.
Patent JP-3935502-B2 (JP)
IPC: C07D211/70
Filed: 1996-02-28
Granted: 2007-06-27
Abstract: The compound of the formula (I) or its salt or a medicament containing the same <CHEM>  wherein,     A and B represent a carbonyl group or sulfonyl group,   m and p are different and represent 0 or 1, R<1> and R<2> may be the same or different from each other and represent a hydrogen atom, an unsubstituted or substituted alkyl group, an unsubstituted or substituted aryl group, an unsubstituted or substituted aralkyl group, an unsubstituted or substituted heterocyclic group containing nitrogen or an unsubstituted or substituted heterocyclic group containing oxygen, or R<1> and R<2>, taken together with the nitrogen atom to which they are linked, may form an unsubstituted or substituted heterocyclic group, provided that when B is a sulfonyl group, R<2> does not represent a hydrogen atom,   n is an integer of 1 to 6,   X represents a methylene group or an oxygen atom, E and Y may be the same or different from each other and represent a hydrogen atom, a halogen atom, an alkoxy group, or an alkyl group which may be substituted by a halogen atom     the dotted line shows the presence or absence of a bond, when said dotted line shows the presence of a bond, Z represents a carbon atom, and when said dotted line shows the absence of a bond, Z represents CH or a nitrogen atom.
Patent JP-3486418-B2 (JP)
IPC: G01N33/68
Filed: 1997-01-17
Granted: 2004-01-13
Abstract: The present invention relates to the use of a reagent that binds specifically to a predetermined ligand, contains one or more antibody constant region epitopes, and is uniform in specificity and affinity. The reagent can be produced continually, in the manufacture of calibrators (standards) and/or controls for diagnostic kits designed to qualitatively or quantitatively measure antibodies specific for a desired ligand. For example, the present invention encompasses recombinant mouse-human chimeric antibodies which may be used as calibrators (standards) and/or positive controls in assays and kits which measure human antibodies. Any species may be used in creating the chimeric antibodies, and the presence of any corresponding species of antibody may be detected.
Patent JP-3341037-B2 (JP)
IPC: H04L1/00
Filed: 1997-05-14
Granted: 2002-11-05
Abstract: This invention concerns a process for transmission of data in the form of digitally encoded radio signals, where the radio signals are comprised of both a data portion and a protocol portion. This process for achieving high quality data transmission is characterized by the fact that the transmission of the data part is started before, during, or simultaneously with the processing of the protocol portion in a transmission relay.
Patent JP-4472789-B2 (JP)
IPC: H01L21/205
Filed: 1998-03-26
Granted: 2010-06-02
Abstract: A method and apparatus for controlling deposit build-up on an interior surface of a dielectric member of a plasma processing chamber. The deposit build-up is controlled by selective ion bombardment of the inner surface by shifting location of a peak voltage amplitude of a voltage standing wave on an antenna such as a flat spiral coil of the plasma processing chamber. A region of high ion bombardment on the interior surface of the dielectric member is displaced by controlling the value of a termination capacitance over a range of values causing regions of low and high ion bombardment to move over the dielectric member in order to effect cleaning thereof.
Patent JP-4335319-B2 (JP)
IPC: D21H21/02
Filed: 1998-04-24
Granted: 2009-09-30
Abstract: Paper, board and cardboard are produced by draining paper stock containing interfering substances in the presence of fixing agents by a process in which the fixing agents used are reaction products which are obtainable by reacting amino- and/or ammonium-containing polymers selected from the group consisting of thepolymers containing vinylamine unitspolyalkylene polyaminespolyamidoaminesethyleneimine-grafted polyamidoamines which may be crosslinked,polydiallyldimethylammonium chloridespolymers containing dialkylaminoalkylacrylamide units or dialkylaminoalkylmethacrylamide units andpolyallylamines anddicyandiamide and formaldehyde condensateswith reactive sizes for paper in a weight ratio of polymer to reactive size of from 15,000:1 to 1:1, and the reaction products thus obtainable are used as fixing agents for water-soluble and for water-insoluble interfering substances in the production of paper, board and cardboard from paper stocks containing interfering substances.
Patent ES-2526096-B2 (ES)
Title: Dispositivo para tratamiento de la aniseiconía con gafas imantadas en puente
Inventor: BERNARDEZ VILABOA RICARDO
IPC: G02C13/00
Filed: 2013-06-28
Granted: 2015-12-18
Abstract: Dispositivo para tratamiento de la aniseiconía con gafas imantadas en puente.#Se presenta un dispositivo que permite el tratamiento de la aniseiconía o diferencia de imagen retiniana con gafas imantadas en su puente.#Consiste básicamente en una barra metálica de un material ligero, fácil de cortar e imantable, para producir un importante cambio en la estructura de unas gafas especifica al permitir cambio sagital del puente de apoyo con la posibilidad de modificar los oculares en función de la diferencia de imágenes retinianas.#La mayor ventaja es la sujeción del puente de unas gafas imantadas convencionales con la introducción de la escala de medida incluida en su cuerpo para una medida precisa. Este nuevo dispositivo elimina al mínimo los problemas de aniseiconía.
Patent AU-2001249497-B2 (AU)
Title: Stoppering method to maintain sterility
Inventor: BARRETT CHRISTOPHER J
IPC: A61M5/315
Filed: 2001-03-27
Granted: 2005-07-14
Abstract: A syringe assembly is provided which includes a hollow barrel that has an interior wall. The interior wall defines a chamber that retains medication. The hollow barrel also includes a distal end and a proximal end. The distal end of the hollow barrel has a passageway that is in contact with the chamber. The proximal end of the hollow barrel has an aperture. The syringe assembly also includes a primary plunger tip that is slidably positioned, in fluid tight engagement, with the interior wall. The primary plunger tip has a receptor to engage an engager of an elongated tip plunger rod. The syringe assembly also includes a secondary plunger tip that is slidably positioned, in fluid tight engagement, with the interior wall. The secondary plunger tip also has a receptor to engage an engager of a tip plunger rod. The secondary plunger tip is disposed between the primary plunger tip and the proximal end of the hollow barrel. The syringe assembly also includes a tip plunger rod, which facilitates operation of the secondary plunger tip, engaged to the secondary plunger tip. The present invention also provides a process for providing a lyophilized medication (i.e., lyophilizate) in a syringe assembly and also provides a process for reconstituting a medication in a syringe assembly.
Patent AU-2002326748-B2 (AU)
Title: Substituted anthranilamides for controlling invertebrate pests
Inventor: MCGANN STEPHEN FREDERICK
IPC: A61K31/4545
Filed: 2002-08-13
Granted: 2008-06-26
Abstract: This invention provides compounds of Formula I, and N-oxides and salts thereof wherein A, B, R1 through R5, R7 through R9, X and Y are as defined in the disclosure. Also disclosed are methods for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound of Formula I. Also disclosed are compositions for controlling an invertebrate pest comprising the compounds of Formula I.
Patent AU-2002343720-B2 (AU)
Title: Transport format combination selection for compressed mode in a W-CDMA system
Inventor: VAYANOS ALKINOOS HECTOR
IPC: H04B7/005
Filed: 2002-11-12
Granted: 2008-11-20
Abstract: Techniques for determining valid (i.e., supported) TFCs from among all configured TFCs for normal and compressed modes. These techniques maintain sufficient historical information such that 'TFC qualification' may be accurately performed. In a first scheme, Tx_power-requirement states are maintained for different combinations of each TFC. One combination is applicable for each TFC at each TFC interval, and valid TFCs are determined from applicable combinations in the proper state(s). In a second scheme, two Tx_power_requirement states are maintained for each TFC for the normal and compressed modes. In a third scheme, a single Tx_power_requirement state is maintained for each TFC for both modes based on a particular relative power requirement. In a fourth scheme, Tx_power_requirement states are maintained for a set of relative 'bins' that cover the total range of required transmit power for all TFCs. And in a fifth scheme, a set of relative power requirement thresholds are maintained.
Patent AU-2003207321-B2 (AU)
Title: MHC class I peptide epitopes from the human 5T4 tumor-associated antigen
Inventor: CARROLL MILES
IPC: C12N5/09
Filed: 2003-02-13
Granted: 2009-01-29
Abstract: There is provided an MHC class I peptide epitope from 5T4 antigen. In particular, there is provided a peptide epitope of 5T4 which comprises one of the following: (i) the amino acid sequence shown as SEQ ID NO: 2; (ii) the minimal epitope from the amino acid sequence shown as SEQ ID NO: 3; (iii) the minimal epitope from the amino acid sequence shown as SEQ ID NO: 4; (iv) the minimal epitope from the amino acid sequence shown as SEQ ID NO: 5; (v) the minimal epitope from the amino acid sequence shown as SEQ ID NO: 6; (vi) the minimal epitope from the amino acid sequence shown as SEQ ID NO: 7. There is also provided a vaccine comprising such a peptide (or precursor thereof) and its use to treat and/or prevent a disease, in particular a cancerous disease.
Patent AU-2003277032-B2 (AU)
Title: Toothbrush
Inventor: HOHLBEIN DOUGLAS J
IPC: A61C17/22
Filed: 2003-09-26
Granted: 2010-07-08
Abstract: A toothbrush, comprising: a head including a plurality of cleaning elements extending from a face of the head: the plurality of cleaning elements including; a central cleaning element of densely packed bristles having a free end that forms a cup-shaped area; a closed ring of bristles spaced from and surrounding the central cleaning element, the central cleaning element located within the closed ring; and wherein the central cleaning element and the surrounding closed ring are aligned along a central longitudinal axis of the head; wherein power is provided within the toothbrush to permit movement of the cup-shaped area and/or closed ring by the toothbrush user.
Patent AU-2004233947-B2 (AU)
Title: Device for injecting electromagnetic radiation into a reactor
Inventor: BENJE MICHAEL
IPC: B01J19/12
Filed: 2004-03-01
Granted: 2009-03-05
Abstract: Device for injecting electromagnetic radiation into a reactor and a reactor comprising this device A device for injecting electromagnetic radiation into a reactor for carrying out free-radical gas-phase reactions and a reactor comprising such a device are described. This comprises the elements: a) a compartment which is separated from the reaction space of the reactor and is b) connected to the reaction space of the reactor via at least one opening, c) at least one feed line for introducing a flushing gas into the compartment, and also d) at least one source of electromagnetic radiation which is arranged so that e) the electromagnetic radiation passes through the compartment and the reaction space of the reactor adjoining the compartment. The device and reactor make an increase in the yield of free-radical chain reactions possible.
Patent AU-2005226871-B2 (AU)
Title: Use of sulfonylureas
Inventor: DIETRICH HANSJORG
IPC: A01N47/36
Filed: 2005-03-12
Granted: 2011-07-28
Abstract: The use of compounds of general formula (I) and their salts is disclosed for selectively combating undesirable plant growth in leguminous plant cultures or for non-selectively combating undesirable plant growth. . In the formula (I), A stands for nitrogen or a CR group, R designating hydrogen, alkyl, halogen and haloalkyl; R stands for hydrogen or an optionally substituted residue from the series composed of alkyl, alkoxy, alkoxyalkyl, alkenyl, alkinyl, cycloalkyl, cycloalkylalkyl, aralkyl and aryl; R stands for hydrogen, halogen or optionally halogen-substituted alkyl, alkoxy, alkylthio, alkylamino or dialkylamino having 1-6 carbon atoms; R stands for hydrogen, halogen or optionally halogen-substituted alkyl, alkoxy, alkylthio, alkylamino or dialkylamino having 1-6 carbon atoms; R-R independently stand for hydrogen, halogen, cyano, thiocyanato or optionally halogen-substituted alkyl, alkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl, alkylamino, alkylcarbonyl, alkoxycarbonyl, alkylaminocarbonyl having 1-3 carbon atoms; and R stands for hydrogen, halogen, cyano, thiocyanato or optionally halogen-substituted alkyl, alkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl, alkylamino, alkylcarbonyl, alkoxycarbonyl, alkylaminocarbonyl having 1-3 carbon atoms. In the above-mentioned residues, each of the alkyl and alkylene groups can have 1-6 C atoms, each of the alkenyl and alkinyl groups can have 2-6 C atoms, each of the cycloalkyl groups can have 3-6 C atoms and each of the aryl groups can have 6-10 C atoms.
Patent AU-2005250453-B2 (AU)
Title: Methods and compositions for the inhibition of gene expression
Inventor: SHEIKHNEHJAD GHOLAMREZA
IPC: C12N15/85
Filed: 2005-06-01
Granted: 2012-02-23
Abstract: The present invention relates to methods and compositions for the inhibition of gene expression. In particular, the present invention provides oligonucleotide-based therapeutics for the inhibition of oncogenes involved in cancers.
Patent AU-2005260871-B2 (AU)
Title: Indoor unit of an air conditioner
Inventor: ITO MIKIO
IPC: F24F1/009
Filed: 2005-07-13
Granted: 2008-10-02
Abstract: An indoor unit of an air conditioner includes an indoor unit casing having a first suction port, a panel, a moving mechanism, and a control unit. The panel opens the first suction port by moving so that the panel is spaced apart from the indoor unit casing, and closes the first suction port by moving so that the panel is proximate to the indoor unit casing. The moving mechanism moves the panel so that the first suction port is opened to a desired degree of opening. The control unit controls the moving mechanism. Furthermore, the control unit is capable of modifying the degree of opening of the first suction port to a desired degree of opening.